Inhibikase Therapeutics, Inc.

What is Inhibikase Therapeutics, Inc. (IKT) stock price today?

As of Dec 17, 2025, 9:00 PM UTC, Inhibikase Therapeutics, Inc. (IKT) stock is trading at $1.59. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date IKT stock quotes for informed trading decisions.

What is Inhibikase Therapeutics, Inc.'s market capitalization?

Inhibikase Therapeutics, Inc. (IKT) has a market capitalization of approximately $112.9M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Inhibikase Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the IKT stock price changes.

What is the 52-week range for Inhibikase Therapeutics, Inc. stock?

Inhibikase Therapeutics, Inc. (IKT) stock has traded in a 52-week range of $1.33 — $3.88. The 52-week range shows the highest and lowest prices at which IKT traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Inhibikase Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Inhibikase Therapeutics, Inc. stock have?

Inhibikase Therapeutics, Inc. (IKT) stock recently traded approximately 599.4K shares. Trading volume indicates market liquidity and investor interest in IKT. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Inhibikase Therapeutics, Inc. stock.

Does Inhibikase Therapeutics, Inc. pay dividends to shareholders?

Yes, Inhibikase Therapeutics, Inc. (IKT) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Inhibikase Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Inhibikase Therapeutics, Inc.'s intraday price range?

Today, Inhibikase Therapeutics, Inc. (IKT) stock has traded in a range of $1.55 — $1.64. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring IKT's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Inhibikase Therapeutics, Inc. stock data?

AlphaPilot sources real-time IKT stock quotes, fundamental financial data, and historical price charts for Inhibikase Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Inhibikase Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of IKT stock performance.